Day 1: Luminal Breast Cancer in the picture

It’s the first day at the San Antonio Breast Cancer Symposium (SABCS) 2022.

And at this first day, Luminal Breast Cancer is the topic of the first general session, with exciting presentations both in primary and metastatic breast cancer.

MediMix asked Prof Hans Wildiers from the University Hospital Gasthuisberg, KU Leuven, to give a ten-minute summary of the presented data. The studies being discussed are: monarchE, SWOG S1207, the Right Choice trial, TROPiCS-02 and the RxPONDER trial (SWOG S1007).